Designing and delivering teleradiology services which meet your specific requirements is our forte. Our Board Certified radiologists offer preliminary, final and subspecialty reports 24/7/365. Turnaround times are set to match your needs. Our technical support center provides state of the art PACS/RIS and communication technology, which securely integrates with your current Information Systems.


Teleconsult pathologists offer services ranging from remote reporting of cyto- and histological cases, to lab design and quality assurance programs. We support the most basic lab set ups with second opinions and on-line consultations, and connect more advanced labs to our web based telepathology platform for routine reporting of diverse cases.


Our telemicrobiology services are offered by Dutch and UK Board Certified clinical microbiologists with sub-specialties in the fields of general microbiology, bacteriology, virology, parasitology, mycology, molecular diagnostics and epidemiology. Our clinical microbiologists are mainly active in clinical hospital settings, keeping them closely connected and in tune with daily clinical situations and challenges. This creates affinity with remote cases and ensures the up-to-date knowledge our customers require.

Locum Placement

Our recruitment division recruits certified radiologists, pathologists and micro biologists for part time and full time positions. In our 15 year history we successfully recruited and placed medical specialists in over 60 hospitals and clinics across the globe

Screening & Trials

From its worldwide network of Board Certified medical specialists, TeleConsult creates subspecialty teams for specific screening and clinical trial assignments. In 2012 TeleConsult’s dedicated breast radiologists were selected by the Dutch Breast Cancer Screening program to interpret its screening mammography studies.

We are hiring

We recruit, select and place sub-specialty, EU educated and certified radiologists, pathologists and microbiologists for short and long term positions. Our reputation has been built on a foundation of providing highly skilled doctors and the following core values: Professionalism, Value for money, Quality, Reliability and Integrity. Interested in joining our team? Register now!

Specialist care at your fingertips

Whether you are a hospital  department, diagnostic center or laboratory, Teleconsult doctors and IT experts bring optimal efficiency to your  workflow. A thorough analysis of your current situation, needs and requirements results in a balanced work flow management plan.

Teleconsult does not have any volume requirement and you are in full control to decide when to outsource studies to a Teleconsult doctor. To find out how your clinic or department will benefit from working with Teleconsult Europe, please contact us.


  • Balance on- and off site tasks




About Teleconsult

Founded in 2007 by Dutch radiologists, TeleConsult Europe (TCE) offers radiology services to hospitals, clinics, diagnostic centers, laboratories, medical services companies and the Dutch Government.

TCE’s mission is to provide its customers with tailored telemedicine solutions. Since its inception, TCE carefully listened to wishes and needs of its clients. This resulted in an array of interchangeable services providing radiology and pathology departments with high quality, cost efficient, flexible on- and off-site solutions.

Today TCE’s solutions consist of a combination of an on-site physician workforce, teleradiology, telepathology, and IT services. Our Western Board certified radiologists and pathologists perform reading services for a broad array of institutions varying from a 24/7 emergency reading service for hospitals and clinics, to screening services for the famous Dutch Breast Cancer Screening Program.

The primary objective of our highly trained physicians and staff is to enable our clients to provide optimal patient care and diagnostic services by placing quality and value first. Our synergetic modules provide tailored services to hospitals, clinics and imaging centers at any location on the globe. Whether you need an on-site physician, reports through telemedicine or a combination of both, we help you to realize an optimal and cost efficient workflow.

Majority of false-positive mammograms associated with anxiety, distress

While mammograms are capable of saving the lives of people from breast cancer, a new study suggests their benefits are not universal. Research published in Cancer Epidemiology, Biomarkers & Prevention indicates that many women who receive false-positive results go on to experience psychosocial problems such as anxiety.

In some cases, the study authors noted that negative effects on self-esteem, behavior and sleeping remained for 12 months after receiving the screening result.

According to study author Anetta Bolejko, from the Department of Medical Imaging and Physiology at Skåne University Hospital in Malmö, Sweden, around a third of women involved in the study experienced psychosocial consequences up to 1 year after their diagnostic workup.

"This is important, because women invited to attend mammographic screening should be informed about the potential benefits and harm of the program," she says, "and the risk of long-term psychosocial consequences of false-positive screening mammography should be acknowledged."

Mammography - X-ray imaging of the breast - is one of the most common methods of breast cancer diagnosis. Mammograms make it possible for clinicians to detect tumors that cannot be felt and to check for further evidence of cancer after a lump has been identified.

Unfortunately, mammography is not perfect. Sometimes an abnormal result that suggests cancer is present is later proven to be incorrect. These results are referred to as false-positive results.

Every abnormal result necessitates additional testing to determine whether cancer is present, which means that false-positive results can lead to people undergoing unnecessary procedures, including biopsies. This extra testing can be costly and time-consuming, as well as physically discomforting to patients.

To investigate the psychosocial impact of false-positive results, Dr. Bolejko and her colleagues analyzed the responses of 399 women to the Swedish Consequences of Screening - Breast Cancer (COS-BC) questionnaire.

Each participant was enrolled in the study after being recalled to diagnostic work-up following an abnormal mammogram and their responses were used after breast cancer was not found.

The questionnaire was designed to gauge how the women felt and was initially completed by the women before they were told they were free from cancer. The participants then completed the questionnaire again 6 and 12 months later.

Questionnaires were also completed on the same occasions by 499 age-matched control participants who had negative mammogram results.

Early recall was a predictor of psychosocial distress

The researchers found that large numbers of the participants who received false-positive results experienced negative psychosocial consequences following their mammography but before learning they did not have cancer:

  • 88% reported feeling a sense of dejection
  • 83% reported anxiety
  • 67% reported a negative impact on behavior such as difficulty concentrating
  • 53% reported problems with sleeping.

After the first round of questionnaires, those who had received false-positive results were over five times more likely to report negative psychosocial consequences than the control participants.

This increased likelihood persisted even after 6 and 12 months, with the participants who had received false-positive results more than twice as likely to report psychosocial consequences than the control participants.

After further analysis, the researchers found that one of the predictors of negative psychosocial consequences was early recall for testing - something that Dr. Bolejko says they were surprised to discover:

"We were surprised to find that women who are frequently monitored by additional clinical mammography [early recall] following a false-positive screening mammogram experienced psychosocial consequences. This means that we think that early recall should be applied cautiously because it seems to create confusion and maintain psychosocial distress."

The researchers state that interviews with recalled women have demonstrated support from health care professionals can lead to comfort and security while counseling can lower the risk of psychosocial distress, underlining the importance of personalized face-to-face communication.

"However, additional studies are needed to identify effective methods for facilitating communication and support for diverse populations participating in mammography screening," they conclude.

Recently, Medical News Today reported on a study published in JAMA Oncology that suggested surgery and radiotherapy for ductal carcinoma in situ (DCIS) - an early, noninvasive stage of breast cancer - may be unlikely to reduce risk of death from cancer.

Written by

Powered By | Full Text RSS Feed

Children's hospitals shift from CT scans for common childhood health problems

A study published online Aug. 24 by the journal Pediatrics finds a significant decrease in the use of computed tomography (CT) scans at children's hospitals for 10 common childhood diagnoses including seizure, concussion, appendectomy and upper respiratory tract infection.

Alternate types of imaging such as ultrasound and magnetic resonance imaging (MRI) are being used more frequently for eight of the 10 diagnoses. Study authors hypothesize the decline in CT usage may be attributable to a growing body of evidence linking ionizing radiation from CT scans to an increased risk of cancer in patients. They also point to the adoption of electronic health records, which allows for easy transfer of medical data and images and limits the need for duplicate scans.

The study, "Computed Tomography and Shifts to Alternate Imaging Modalities in Hospitalized Children," is the first of its kinds to look at CT usage across multiple hospitals and conditions.

"This study reinforces the pediatric community's commitment to think about both immediate and long term risks and benefits of our treatment," said Michelle Parker, MD, the study's lead investigator and a physician in the Division of Hospital Medicine at Cincinnati Children's Hospital Medical Center. "Minimizing potential for harm to our patients as we work to heal them should always remain a priority."

A CT scan combines a series of X-ray images taken from different angles and uses computer processing to create cross-sectional images of bones, blood vessels and soft tissues, providing more detail than conventional X-rays. CT scans, however, emit 100 to 1,000 times more ionizing radiation than conventional X-rays.

According to previously published literature, there may be one malignancy as a result of ionizing radiation among every 10,000 children exposed to CT scans. To minimize the risk of cancer in patients requiring sophisticated imaging for diagnostic purposes, when an alternate imaging modality is indicated, doctors may be shifting to MRI which uses magnetic fields or ultrasound, which uses high frequency sound waves to show internal body images in real time.

"There may still be times when a CT scan is the most appropriate imaging tool to use, however parents should be encouraged by this study which shows that physicians and hospitals are likely incorporating new evidence and adapting to provide safe medical care ," said Parker.

The study used data from the Children's Hospital Association's Pediatric Health Information System (PHIS), a comparative pediatric database of clinical and resource utilization information for inpatient, ambulatory surgery emergency department and observation unit patient encounters for 45 children's hospitals. The authors looked at inpatients and observation patients for 10 specific diagnoses at 33 participating hospitals from Jan. 1, 2004 to Dec. 31, 2012. The ten diagnoses analyzed for diagnostic imaging use included seizure, ventricular shunt procedure, craniotomy, concussion, severe head trauma, appendectomy, gastroenteritis, abdominal pain, upper respiratory tract infection and ENT conditions.

Powered By | Full Text RSS Feed

Drug may reduce harm of potentially lethal radiation

Exposure to nuclear radiation in the event of an incident has the potential to injure and kill thousands of people. Emergency measures that can be given in the first 24 hours to limit the damage to the body until better medical care is available can save lives, say researchers who have found a drug that appears to fit this need.

In the journal Laboratory Investigation, a team from the University of Texas Medical Branch (UTMB) at Galveston describes how the experimental drug TP508 showed promising results in tests on mice.

They note how a single injection of TP508, a regenerative peptide, significantly increased survival in mice after exposure to nuclear radiation, even though it was given 24 hours after the exposure occurred.

The drug works by limiting the damage to the gut, says lead author Dr. Carla Kantara, a researcher in biochemistry and molecular biology.

Exposure to high doses of radiation can kill because of various serious effects on the body. One of these effects is gastrointestinal (GI) toxicity syndrome, due to damage to the gut lining.

When the gut lining is damaged, its ability to absorb water during digestion is reduced, increasing the likelihood of imbalances in electrolytes, bacterial infection, leakage from the intestines, sepsis, and death, note the authors.

Senior author Darrell Carney, an adjunct professor in biochemistry and molecular biology, and also CEO of Chrysalis BioTherapeutics, Inc., a company that develops branded drugs like the one tested in the study, says:

"Because radiation-induced damage to the intestines plays such a key role in how well a person recovers from radiation exposure, it's crucial to develop novel medications capable of preventing GI damage."

Drug appears to activate stem cells and preserve crypt cell regeneration

GI toxicity syndrome results from radiation damage to the crypt cells in the small intestine and colon. These cells have to constantly replenish themselves to maintain the health and integrity of gut lining.

Crypt cells are very sensitive to radiation damage and their health is often used as an indicator of a patient's chances of survival following radiation exposure.

The study shows that TP508 appears to reduce the effects of GI toxicity by activating radiation-resistant stem cells and preserving the ability of crypt cells to regenerate themselves to maintain and restore the gut lining.

TP508 is a thrombin peptide developed to stimulate tissue repair following damage to skin, bone and muscle. Previous studies have shown that the drug works by stimulating growth of new blood vessels, restoring blood flow, curbing inflammation and reducing cell death.

Trials in human patients indicate that TP508 speeds up the healing of diabetic foot ulcers and wrist fractures with no serious drug-related side effects. Dr. Kantara concludes:

"The current results suggest that the peptide may be an effective emergency nuclear countermeasure that could be delivered within 24 hours after exposure to increase survival and delay mortality, giving victims time to reach facilities for advanced medical treatment."

The Centers for Disease Control and Prevention (CDC) distinguish between radioactive contamination and radiation exposure - both of which could occur if radioactive materials are released into the environment as the result of a nuclear accident, a natural event, or an act of terrorism.

Radioactive contamination is where radioactive material is deposited on or in an object or person. Radiation exposure occurs when radiation energy - in the form of waves or particles - from radioactive materials penetrate the body. A person exposed to radiation is not necessarily contaminated with radioactive material.

Radiation is all around us and our bodies have ways to deal with the low levels were are exposed to every day. Techniques like X-rays and CT scans use controlled amounts of radiation through the body to produce images. Exposure to small amounts of radiation over a long time can raise a person's risk of cancer. It can also cause mutations in genes that are passed on to offspring.

Exposure to a lot of radiation over a short period - such as from a nuclear accident - causes burns and severe damage to tissues and organs, which is the problem addressed by this study.

Meanwhile, Medical News Today recently learned from a series of articles published in The Lancet, that nowadays, people are more likely to suffer mental illness following a nuclear accident than experience physical effects.

Written by

Powered By | Full Text RSS Feed